SEATTLE, May 21, 2021, (MEDGADGET) — Global Intensity-Modulated Proton Therapy Market
Intensity-modulated proton therapy is a type of proton therapy that uses ionizing radiation. During this therapy, with the help of a proton accelerator, a beam of protons targets the tumor and slows down the growth of the tumor. The treatment is planned carefully by using magnetic resonance (MRI) and computed tomography (CT) of patients to define the dose tolerability suitable to the tumor shape. The treatment time is around 15 minutes to 1 hour, and the equipment used during proton therapy is mainly medical linear accelerators.
For More Information, Request sample copy of Business Report: https://www.coherentmarketinsights.com/insight/request-sample/4106
The emergence of COVID-19 has impacted the global intensity modulated proton therapy market growth. The pandemic has affected demand for proton therapy as cancer patients are at higher risk of getting infected by COVID-19. Moreover, several countries worldwide imposed nationwide lockdown to curb the spread of the virus, which, in turn has made it difficult to administer therapy in cancer patients.
Increasing prevalence of cancer worldwide is expected to people growth of the global intensity-modulated proton therapy market during the forecast period. According to the World Health Organization (WHO), in 2018, cancer accounted for around 9.6 million deaths worldwide.
Moreover, increasing adoption of intensity-modulated proton therapy, as it is safe and effective for the cancer treatment, is expected to drive the global intensity-modulated proton therapy market growth. For instance, in February 2020, IBA Ion Bean Application signed a contract to install Proteus ONE, a compact proton therapy at RSPAD Gatot Soebroto Presidential Hospital in Jakarta, Indonesia.
Direct Purchase the Intensity Modulated Proton Therapy Market Report 2021 @ https://www.coherentmarketinsights.com/insight/buy-now/4106
High cost of set-up, as well as high cost of proton therapy is expected to hinder the global intensity-modulated proton therapy market growth over the forecast period. According to The Institute of Clinical and Economic Review, the cost of proton therapy in the United States is US$ 73,000.
By Treatment Type:
- Multiple Room
- Single Room
- Pediatric Cancer
- Lung Cancer
- Brain Cancer
- Prostate Cancer
- Gastro-intestinal Cancer
- Head and Neck Cancer
- Asia Pacific
- Latin America
- North America
- Middle East
North America is expected to witness significant growth in the global intensity-modulated proton therapy market due to increasing prevalence of cancer and increasing research and development by market players. For instance, in October 2018, Varian announced its new single-room proton therapy system, ProBeam 360°. The system has a 360-degree rotating gantry, the most powerful particle accelerator available today to treat cancer, iterative cone-beam CT imaging and high-definition pencil-beam scanning technology.
Europe is also expected to witness substantial growth in the global intensity-modulated proton therapy market, owing to the increasing prevalence of cancer and an increasing number of mergers and acquisitions by market players. Market players are adopting various strategies to strengthen their market position. According to the European Journal of Cancer, in Europe, cancer accounted for around 1.9 million deaths in 2018.
Moreover, Asia Pacific is expected to witness significant growth in the global intensity-modulated proton therapy market owing to the increasing number of healthcare facilities in the region. For instance, in 2019, Apollo Hospitals opened South East Asia’s first proton therapy centre for cancer in India to provide patients with a specialized form of radiotherapy that is extremely precise in destroying cancer cells.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/intensity-modulated-proton-therapy-market-4106
Major players active in the global intensity-modulated proton therapy market are Mitsubishi Electric Corp., ProNova Solutions, Varian Medical Systems, Hitachi Ltd, Sumitomo Heavy Industries, Ltd, Ion Beam Applications S.A., Proton International, Mevion Medical Systems, and Apollo Hospitals Enterprise Limited.
In 2019, Ion Beam Application S.A signed an agreement with University of Kansas Health System to establish proton therapy centre at the main campus of University in Kansas, with intensity modulated proton therapy.
In 2018, the Miami Cancer Institute started South Florida’s First proton therapy centre with intensity modulated proton therapy.
Table of Content
Global Intensity-Modulated Proton Therapy Market Research Report
Section 1: Global Intensity-Modulated Proton Therapy Industry Overview
Section 2: Global Economic Impact on Intensity-Modulated Proton Therapy Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Intensity-Modulated Proton Therapy Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Intensity-Modulated Proton Therapy Market Forecast
Have a Look at Related Research Insights:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027